Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria Giovanna Danieli"'
Autor:
Maria Giovanna Danieli, Jacopo Umberto Verga, Cristina Mezzanotte, Irene Terrenato, Silvia Svegliati, Maria Beatrice Bilo, Gianluca Moroncini
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2022)
Frontiers in Immunology, Vol 12 (2022)
BackgroundImmunoglobulin (Ig) replacement therapy represents a life-saving treatment in primary antibody deficiencies. The introduction of subcutaneous Ig (SCIg) administration brings a major improvement in quality of life for patients, compared to t
Autor:
Moumita Chatterjee, Soumendra Nath Haldar, Anneke J. van der Kooi, Rudra Prosad Goswami, Joost Raaphorst, Pallavi Vij, Chiara Gelardi, Danveer Bhadu, Maria Giovanna Danieli, Uma Kumar, Johan Lim
Publikováno v:
Autoimmunity reviews. 21(2)
Objective To perform a systematic review and meta-analysis on the efficacy and safety of intravenous (IVIg) and subcutaneous (SCIg) immunoglobulin (Ig) therapy in the treatment of idiopathic inflammatory myopathy (IIM) and juvenile dermatomyositis (J
Autor:
Maria Giovanna Danieli, Alessandro Tonacci, Alberto Paladini, Eleonora Longhi, Gianluca Moroncini, Alessandro Allegra, Francesco Sansone, Sebastiano Gangemi
Publikováno v:
Autoimmunity Reviews. 21:103105
To evaluate the response to treatment with intravenous (IVIg) and subcutaneous (20%SCIg) immunoglobulin in our series of patients with Inflammatory idiopathic myopathies (IIM) by the means of artificial intelligence.IIM are rare diseases mainly invol
Autor:
Chiara Gelardi, Armando Gabrielli, Veronica Pedini, Denise Menghini, Maria Giovanna Danieli, Devis Benfaremo
Publikováno v:
Autoimmunity reviews. 19(1)
MGD and CG were responsible for the study's conception and design. VP and DM contributed to data acquisition. VP and DB planned and performed the statistical analyses. All Authors contributed to data interpretation. MGD, CG, VP and DM drafted the man
Autor:
Francesco Logullo, Veronica Pedini, Chiara Gelardi, Armando Gabrielli, Romina Moretti, Maria Giovanna Danieli
Publikováno v:
Autoimmunity Reviews. 13:1182-1188
Intravenous immunoglobulin (IVIg) constitutes a relevant treatment option in various immune-mediated disorders, such as chronic inflammatory neuropathies and idiopathic inflammatory myopathies (IIM). Several advantages are linked to IVIg immunomodula
Autor:
Katalin Dankó, W. E. R. Ollier, Olivier Benveniste, Paula Jordan, Jiri Vencovsky, B. De Paepe, M Vázquez-Del Mercado, Ingrid E. Lundberg, Lucy R. Wedderburn, Guochun Wang, Robert G. Cooper, Nicolò Pipitone, Øyvind Molberg, Zoe E Betteridge, Janine A. Lamb, Niels Steen Krogh, Neil McHugh, Paul New, Maria Giovanna Danieli, Louise C. Pyndt Raun Diederichsen, James B. Lilleker, Jens Schmidt, Nguyen Thi Phuong Thuy, Hector Chinoy, J. De Bleecker, Britta Maurer
Publikováno v:
Poster Presentations.
Background The idiopathic inflammatory myopathies (IIM) represent a rare and heterogeneous group of multisystem autoimmune diseases. The rarity of IIM has hampered research efforts, resulting in remarkably limited therapeutic evidence. The EuroMyosit
Autor:
Katalin Dankó, Guochun Wang, Zoe E Betteridge, Neil McHugh, Paula Jordan, James B. Lilleker, Ingrid E. Lundberg, Olivier Benveniste, Paul New, Lucy R. Wedderburn, Nguyen Thi Phuong Thuy, Robert G. Cooper, Niels Steen Krogh, Mónica Vázquez-Del Mercado, Jan De Bleecker, Hector Chinoy, Boel De Paepe, Britta Maurer, Helena Andersson, all EuroMyositis contributors, Louise C. Pyndt Raun Diederichsen, Jiri Vencovsky, Maria Giovanna Danieli, Nicolò Pipitone, Janine A. Lamb, William E R Ollier, Jens Schmidt, Liza J McCann
Publikováno v:
Lilleker, J B, Vencovsky, J, Wang, G, Wedderburn, L R, Diederichsen, L P, Schmidt, J, Jordan, P, Benveniste, O, Danieli, M G, Dankó, K, Phuong Thuy, N T, Mercado, M V-D, Andersson, H, Paepe, B D, De Bleecker, J L, Maurer, B, McCann, L J, Pipitone, N, McHugh, N, Betteridge, Z, New, P, Cooper, R G, Ollier, W E, Lamb, J A, Krogh, N S, Lundberg, I E & Chinoy, H 2018, ' Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2017-212382, https://doi.org/10.1136/annrheumdis-2017-212382
Lilleker, J B, Vencovsky, J, Wang, G, Wedderburn, L R, Diederichsen, L P, Schmidt, J, Jordan, P, Benveniste, O, Danieli, M G, Dankó, K, Phuong Thuy, N T, Mercado, M V-D, Andersson, H, Paepe, B D, De Bleecker, J L, Maurer, B, McCann, L J, Pipitone, N, McHugh, N, Betteridge, Z, New, P, Cooper, R G, Ollier, W E, Lamb, J A, Krogh, N S, Lundberg, I E, Chinoy, H & all EuroMyositis contributors 2018, ' Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al ', Annals of the Rheumatic Diseases, vol. 77, no. 8, e51, pp. e51 . https://doi.org/10.1136/annrheumdis-2017-212382
Lilleker, J B, Vencovsky, J, Wang, G, Wedderburn, L R, Diederichsen, L P, Schmidt, J, Jordan, P, Benveniste, O, Danieli, M G, Dankó, K, Phuong Thuy, N T, Mercado, M V-D, Andersson, H, Paepe, B D, De Bleecker, J L, Maurer, B, McCann, L J, Pipitone, N, McHugh, N, Betteridge, Z, New, P, Cooper, R G, Ollier, W E, Lamb, J A, Krogh, N S, Lundberg, I E, Chinoy, H & all EuroMyositis contributors 2018, ' Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al ', Annals of the Rheumatic Diseases, vol. 77, no. 8, e51, pp. e51 . https://doi.org/10.1136/annrheumdis-2017-212382
We thank Cavagna et al 1 for their thoughtful analysis relating to our recent publication.2 Several important points are raised, many of which we also referred to. It is of great interest and reassurance that the demographics and clinical features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fa0e8279448aa387a4dd5fd43509a5
Autor:
Veronica Pedini, Armando Gabrielli, Maria Giovanna Danieli, Chiara Gelardi, Francesco Logullo
Publikováno v:
Current rheumatology reviews. 14(3)
The efficacy of subcutaneous immunoglobulin is reported in several neurological disorders and, more recently, its use has been extended to other inflammatory diseases, such as the idiopathic inflammatory myopathies, including polymyositis and dermato
Autor:
Maria Giovanna Danieli, Armando Gabrielli, Francesco Logullo, Lucia Pettinari, Romina Moretti
Publikováno v:
Autoimmunity reviews. 10(3)
Objectives To describe the feasibility and safety of subcutaneous immunoglobulin (SCIg) in polymyositis (PM) and dermatomyositis (DM). Methods Since 2009, we used SCIg to treat patients with severe idiopathic myositis (4 with DM, 3 with PM), diagnose
Autor:
Ricardo U. Sorensen, Fabian Käsermann, James B. Bussel, A. Winkelmann, Matthew Helbert, Eduardo Fernández-Cruz, Hans-Hartmut Peter, Srini V. Kaveri, Jagadeesh Bayry, Abdulgabar Salama, N. Cantoni, I. N. van Schaik, Isabella Quinti, Maria Giovanna Danieli, Peter J. Späth, A. Durandy, Nobuhiro Yuki
Publikováno v:
Clinical and experimental immunology, 158(Suppl. 1), 60-67. Wiley-Blackwell
Summary The posters presented at the 6th International Immunoglobulin Symposium covered a wide range of fields and included both basic science and clinical research. From the abstracts accepted for poster presentation, 12 abstracts were selected for